CHOP

Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a potentially safer and more effective gene therapy vector for blood disorders. The newly-developed gene therapy vector will focus on blood disorders like sickle cell disease and beta-thalassemia. It is being considered potentially safer and effective than those currently used in gene therapy trials for these conditions. The findings […]